C-reactive protein in chronic heart failure: A new predictor of survival

Received 4 October 2007; accepted 15 December 2007. published online 23 May 2008.

Abstract

High CRP levels are associated with adverse outcomes in cardiovascular diseases. hsCRP levels increase with the severity of CHF in patients with diastolic HF as well as in systolic HF. This supports a potential role for CRP in immune activation not only in systolic but also in diastolic HF. The measurement of hsCRP levels thus has the potential to play an important role for risk assessment in patients with CHF.

Keywords: Heart failure, Prognosis, C-reactive protein

a Gulhane Military Medical Academy, School of Medicine, Department of Cardiology, 06018 Etlik-Ankara, Turkey

b Sarikamis Army District Hospital, Department of Cardiology, Sarikamis, Turkey

c Gulhane Military Medical Academy, Haydarpasa Training Hospital, Department of Cardiology, Kadikoy-Istanbul, Turkey

Corresponding author. Tel.: +90 312 3044268; fax: +90 312 3044250.

PII: S0167-5273(08)00280-5

doi:10.1016/j.ijcard.2007.12.116

21 of 36